Brendan Saloner, PhD, is a Bloomberg Associate Professor of Addiction and Overdose at the Bloomberg School of Public Health. One strand of his research focuses on access and quality of care for people with mental health and substance use disorders. Professor Saloner has investigated the impact of federal and state policies regarding insurance coverage and benefit design related to substance use disorders on access to care and outcomes related to treatment. Dr. Saloner has examined the ability of people in the criminal legal system to access evidence-based substance use disorder treatment. He received an early career award from the National Institute on Drug Abuse to study the effects of Medicaid program design on treatment for opioid use disorder. Another strand of his research focuses broadly on insurance expansions and safety net programs for low-income populations. He has published widely on access to primary care services in relation to the Affordable Care Act Medicaid expansion. He has also published on Medicaid redesign related to premiums and cost-sharing and on public insurance programs for children and adolescents. Finally, Professor Saloner has studied the ethics of resource allocation and normative issues related to health insurance policy.

Dr. Saloner received his PhD from Harvard University and his bachelor’s degree from the University of California, Berkeley.

Related work